Coherus Biosciences Inc. Price to FCF Ratio 2014–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Coherus Biosciences Inc. (CHRS): market cap divided by trailing twelve-month free cash flow. As of September 30, 2021 it is 8.64.

From: 06/30/2016To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Coherus Biosciences Inc. Price to FCF Ratio — FAQ

Coherus Biosciences Inc. (CHRS) price to fcf ratio over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CHRS's price to fcf ratio history?

The chart and table above show Coherus Biosciences Inc.'s price to fcf ratio by year and by quarter, including the growth rate.